Latilactobacillus sakei WIKIM31 Decelerates Weight Gain in High-Fat Diet-Induced Obese Mice by Modulating Lipid Metabolism and Suppressing Inflammation

Obesity and related metabolic diseases are major problems worldwide. Some probiotics are currently considered potential therapeutic strategies for obesity. We aimed to investigate the antiobesity efficacy of Latilactobacillus sakei WIKIM31 in obese mice induced by a high fat diet. The administration of a high-fat diet with L. sakei WIKIM31 reduced body weight gain, epididymal fat mass, triglyceride and total cholesterol levels in the blood, and remarkably decreased the expression of lipogenesis-related genes in the epididymal adipose tissue and liver. Interestingly, intake of L. sakei WIKIM31 improved gut barrier function by increasing the gene expression of tight junction proteins and suppressing the inflammatory responses. Additionally, L. sakei WIKIM31 enhanced the production of short-chain fatty acids, such as butyrate and propionate, in the intestinal tract. These results showed that L. sakei WIKIM31 can be used as a potential therapeutic probiotic for obesity.

[1]  J. Yoon,et al.  Isolation of lactic acid bacteria from kimchi and screening of Lactobacillus sakei ADM14 with anti-adipogenic effect and potential probiotic properties , 2020 .

[2]  Jingjing Lu,et al.  Probiotic Mixture of Lactobacillus plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice , 2020, Frontiers in Microbiology.

[3]  Young Joon Oh,et al.  Mixture of Two Lactobacillus plantarum Strains Modulates the Gut Microbiota Structure and Regulatory T Cell Response in Diet‐Induced Obese Mice , 2018, Molecular nutrition & food research.

[4]  Namhee Kim,et al.  Lactobacillus sakei WIKIM30 Ameliorates Atopic Dermatitis-Like Skin Lesions by Inducing Regulatory T Cells and Altering Gut Microbiota Structure in Mice , 2018, Front. Immunol..

[5]  S. Ryu,et al.  Mechanisms regulating intestinal barrier integrity and its pathological implications , 2018, Experimental & Molecular Medicine.

[6]  M. Priyadarshini,et al.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology. , 2018, Comprehensive Physiology.

[7]  Han-Seung Shin,et al.  Benefaction of probiotics for human health: A review , 2018, Journal of food and drug analysis.

[8]  B. Shi,et al.  Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics , 2017, Cell & Bioscience.

[9]  D. Bessesen,et al.  Progress and challenges in anti-obesity pharmacotherapy. , 2017, The lancet. Diabetes & endocrinology.

[10]  P. Dhawan,et al.  Obesity-induces Organ and Tissue Specific Tight Junction Restructuring and Barrier Deregulation by Claudin Switching , 2017, Scientific Reports.

[11]  J. Nicholson,et al.  Impact of the gut microbiota on inflammation, obesity, and metabolic disease , 2016, Genome Medicine.

[12]  J. B. Kim,et al.  Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders , 2016, Front. Endocrinol..

[13]  Dong-Hyun Kim,et al.  Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota LPS production and inducing colon tight junction protein expression , 2015 .

[14]  Y. Abed,et al.  Obesity and inflammation: the linking mechanism and the complications , 2016, Archives of medical science : AMS.

[15]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[16]  Yi-Fan Hong,et al.  Different immune regulatory potential of Lactobacillus plantarum and Lactobacillus sakei isolated from Kimchi. , 2014, Journal of microbiology and biotechnology.

[17]  O. Martínez-Augustin,et al.  Intestinal Inflammation and Mucosal Barrier Function , 2014, Inflammatory bowel diseases.

[18]  Kassem M. Makki,et al.  Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines , 2013, ISRN inflammation.

[19]  Myung‐Sook Choi,et al.  Probiotics L. plantarum and L. curvatus in Combination Alter Hepatic Lipid Metabolism and Suppress Diet‐Induced Obesity , 2013, Obesity.

[20]  J. Clemente,et al.  Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice , 2013, Science.

[21]  C. Jeon,et al.  Microbial succession and metabolite changes during long-term storage of Kimchi. , 2013, Journal of food science.

[22]  Patrice D Cani,et al.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity , 2012, Gut microbes.

[23]  S. Bernard,et al.  Dynamics of human adipose lipid turnover in health and metabolic disease , 2011, Nature.

[24]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[25]  D. Nie,et al.  G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer , 2011, International journal of cancer.

[26]  K. Imaizumi,et al.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial , 2010, European Journal of Clinical Nutrition.

[27]  Laxman Yetukuri,et al.  The gut microbiota modulates host energy and lipid metabolism in mice[S] , 2010, Journal of Lipid Research.

[28]  Patrice D Cani,et al.  The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.

[29]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[30]  J. Meddings.  The significance of the gut barrier in disease , 2007, Gut.

[31]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[32]  Janardan K Reddy,et al.  Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[33]  JORGE BEJARANO.  [Significance of WHO]. , 1953, Revista colombiana de pediatria y puericultura.